ImportRefusal LogoImportRefusal

Glenmark Pharmaceuticals Limited

⚠️ High Risk

FEI: 3008191605 • Solan, Himachal Pradesh • INDIA

FEI

FEI Number

3008191605

📍

Location

Solan, Himachal Pradesh

🇮🇳

Country

INDIA
🏢

Address

Unit 11, Village Bhattanwala, P.o. Pajpura, Solan, Himachal Pradesh, India

High Risk

FDA Import Risk Assessment

65.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

8
Total Refusals
2
Unique Violations
12/2/2025
Latest Refusal
4/6/2016
Earliest Refusal

Score Breakdown

Violation Severity
85.6×40%
Refusal Volume
35.3×30%
Recency
97.6×20%
Frequency
8.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

758×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
12/2/2025
61WDY04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/12/2024
56DDY41NEOMYCIN SULFATE (AMINOGLYCOSIDES)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/1/2024
62CDL41MINOXIDIL (ANTI-HYPERTENSIVE)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/23/2017
62FCJ53MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2017
63VCJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2017
61FCY54CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/28/2016
64LDJ67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/6/2016
62JDY13DONEPEZIL HCL (ANTI-PARKINSONIAN)
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Glenmark Pharmaceuticals Limited's FDA import refusal history?

Glenmark Pharmaceuticals Limited (FEI: 3008191605) has 8 FDA import refusal record(s) in our database, spanning from 4/6/2016 to 12/2/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glenmark Pharmaceuticals Limited's FEI number is 3008191605.

What types of violations has Glenmark Pharmaceuticals Limited received?

Glenmark Pharmaceuticals Limited has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glenmark Pharmaceuticals Limited come from?

All FDA import refusal data for Glenmark Pharmaceuticals Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.